Terms: = Colorectal cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
67 results:
1. Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer.
Moll GN
Eur J Pharmacol; 2024 Sep; 978():176772. PubMed ID: 38925290
[TBL] [Abstract] [Full Text] [Related]
2. Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis.
Ma Z; Sun Y; Yu Y; Xiao W; Xiao Z; Zhong T; Xiang X; Li Z
Cell Commun Signal; 2024 May; 22(1):295. PubMed ID: 38802814
[TBL] [Abstract] [Full Text] [Related]
3. High expression of SHP2 predicts a promising prognosis in colorectal cancer.
Liu X; Li M; Chen L; Wen F; Zheng S; Ge W
Indian J Pathol Microbiol; 2024; 67(1):29-35. PubMed ID: 38358185
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Liu C; Shen A; Song J; Cheng L; Zhang M; Wang Y; Liu X
Cancer Commun (Lond); 2024 Jan; 44(1):76-100. PubMed ID: 38010289
[TBL] [Abstract] [Full Text] [Related]
5. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
[TBL] [Abstract] [Full Text] [Related]
6. Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the src/mTOR signaling pathway.
Zheng W; Guo Y; Zhang G; Bai J; Song Y; Song X; Zhu Q; Bao X; Wu G; Zhang C
PLoS One; 2023; 18(6):e0287133. PubMed ID: 37347740
[TBL] [Abstract] [Full Text] [Related]
7. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and src.
Chen X; Chen J; Feng W; Huang W; Wang G; Sun M; Luo X; Wang Y; Nie Y; Fan D; Wu K; Xia L
Theranostics; 2023; 13(4):1401-1418. PubMed ID: 36923538
[No Abstract] [Full Text] [Related]
8. A reversible src-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF
Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
[TBL] [Abstract] [Full Text] [Related]
9. Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration.
Jiang XF; Zhang BM; Du FQ; Guo JN; Wang D; Li YE; Deng SH; Cui BB; Liu YL
Front Immunol; 2022; 13():1013828. PubMed ID: 36569844
[TBL] [Abstract] [Full Text] [Related]
10. THUMPD3-AS1 facilitates cell growth and aggressiveness by the miR-218-5p/SKAP1 axis in colorectal cancer.
Pu Y; Wei J; Wu Y; Zhao K; Wu Y; Wu S; Yang X; Xing C
Cell Biochem Biophys; 2022 Sep; 80(3):483-494. PubMed ID: 35538197
[TBL] [Abstract] [Full Text] [Related]
11. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and src targeted therapy.
Yang M; Davis TB; Pflieger L; Nebozhyn MV; Loboda A; Wang H; Schell MJ; Thota R; Pledger WJ; Yeatman TJ
BMC Cancer; 2022 Mar; 22(1):256. PubMed ID: 35272617
[TBL] [Abstract] [Full Text] [Related]
12. G-protein coupled receptor 34 regulates the proliferation and growth of LS174T cells through differential expression of PI3K subunits and PTEN.
Zuo B; Wu N; Yang S; Zhong Z; Li M; Yu X; Liu Y; Yu W
Mol Biol Rep; 2022 Apr; 49(4):2629-2639. PubMed ID: 34997428
[TBL] [Abstract] [Full Text] [Related]
13. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract] [Full Text] [Related]
14. p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.
Rampioni Vinciguerra GL; Dall'Acqua A; Segatto I; Mattevi MC; Russo F; Favero A; Cirombella R; Mungo G; Viotto D; Karimbayli J; Pesce M; Vecchione A; Belletti B; Baldassarre G
Cell Death Dis; 2021 Oct; 12(10):951. PubMed ID: 34654798
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/src pathway.
Zhang W; Pan R; Lu M; Zhang Q; Lin Z; Qin Y; Wang Z; Gong S; Lin H; Chong S; Lu L; Liao W; Lu X
Oncogene; 2021 Nov; 40(45):6369-6380. PubMed ID: 34588619
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic significance of different proportion of signet-ring cells of colorectal carcinoma.
Chen W; Cai H; Chen K; Liu X; Jiang W; Li S; Zhang Y; Chen Z; Guan G
Bosn J Basic Med Sci; 2022 Feb; 22(1):124-130. PubMed ID: 34247568
[TBL] [Abstract] [Full Text] [Related]
17. [Value of prediction models for prognosis prediction of colorectal cancer: an analysis based on TCPA database].
Wen H; Shi W; Ge S; Li J; Zuo L; Liu M
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):439-446. PubMed ID: 33849837
[TBL] [Abstract] [Full Text] [Related]
18. Anti-GPR56 monoclonal antibody potentiates GPR56-mediated src-Fak signaling to modulate cell adhesion.
Chatterjee T; Zhang S; Posey TA; Jacob J; Wu L; Yu W; Francisco LE; Liu QJ; Carmon KS
J Biol Chem; 2021; 296():100261. PubMed ID: 33837725
[TBL] [Abstract] [Full Text] [Related]
19. MUC Glycoproteins: Potential Biomarkers and Molecular Targets for cancer Therapy.
Ratan C; Cicily K D D; Nair B; Nath LR
Curr Cancer Drug Targets; 2021; 21(2):132-152. PubMed ID: 33200711
[TBL] [Abstract] [Full Text] [Related]
20. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5
Feng H; Liu K; Shen X; Liang J; Wang C; Qiu W; Cheng X; Zhao R
Cell Death Dis; 2020 Oct; 11(10):916. PubMed ID: 33099574
[TBL] [Abstract] [Full Text] [Related]
[Next]
